vs

Side-by-side financial comparison of NAPCO SECURITY TECHNOLOGIES, INC (NSSC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $48.2M, roughly 1.6× NAPCO SECURITY TECHNOLOGIES, INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 12.2%). NAPCO SECURITY TECHNOLOGIES, INC produced more free cash flow last quarter ($14.5M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -1.1%).

Napco Security Technologies, Inc. was set up in 1969 and now is based in Amityville, New York. The company focuses on security products, such as electronic locking devices, alarm systems, and building access control systems. The company was formerly known as Napco Security Systems, Inc.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

NSSC vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.6× larger
PBYI
$75.5M
$48.2M
NSSC
Growing faster (revenue YoY)
PBYI
PBYI
+15.5% gap
PBYI
27.7%
12.2%
NSSC
More free cash flow
NSSC
NSSC
$130.0K more FCF
NSSC
$14.5M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-1.1%
NSSC

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
NSSC
NSSC
PBYI
PBYI
Revenue
$48.2M
$75.5M
Net Profit
$13.5M
Gross Margin
58.6%
69.3%
Operating Margin
30.6%
22.7%
Net Margin
28.0%
Revenue YoY
12.2%
27.7%
Net Profit YoY
29.0%
EPS (diluted)
$0.38
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NSSC
NSSC
PBYI
PBYI
Q4 25
$48.2M
$75.5M
Q3 25
$49.2M
$54.5M
Q2 25
$50.7M
$52.4M
Q1 25
$44.0M
$46.0M
Q4 24
$42.9M
$59.1M
Q3 24
$44.0M
$80.5M
Q2 24
$50.3M
$47.1M
Q1 24
$49.3M
$43.8M
Net Profit
NSSC
NSSC
PBYI
PBYI
Q4 25
$13.5M
Q3 25
$12.2M
$8.8M
Q2 25
$11.6M
$5.9M
Q1 25
$10.1M
$3.0M
Q4 24
$10.5M
Q3 24
$11.2M
$20.3M
Q2 24
$13.5M
$-4.5M
Q1 24
$13.2M
$-4.8M
Gross Margin
NSSC
NSSC
PBYI
PBYI
Q4 25
58.6%
69.3%
Q3 25
56.6%
77.7%
Q2 25
52.8%
76.5%
Q1 25
57.2%
77.1%
Q4 24
57.0%
76.4%
Q3 24
55.9%
63.9%
Q2 24
55.3%
77.4%
Q1 24
53.8%
75.5%
Operating Margin
NSSC
NSSC
PBYI
PBYI
Q4 25
30.6%
22.7%
Q3 25
27.7%
17.6%
Q2 25
23.8%
12.7%
Q1 25
25.4%
8.7%
Q4 24
26.0%
22.6%
Q3 24
26.9%
27.4%
Q2 24
27.7%
-4.6%
Q1 24
29.4%
-5.3%
Net Margin
NSSC
NSSC
PBYI
PBYI
Q4 25
28.0%
Q3 25
24.7%
16.2%
Q2 25
22.9%
11.2%
Q1 25
23.0%
6.5%
Q4 24
24.4%
Q3 24
25.4%
25.2%
Q2 24
26.9%
-9.6%
Q1 24
26.8%
-11.0%
EPS (diluted)
NSSC
NSSC
PBYI
PBYI
Q4 25
$0.38
$0.26
Q3 25
$0.34
$0.17
Q2 25
$0.33
$0.12
Q1 25
$0.28
$0.06
Q4 24
$0.28
$0.40
Q3 24
$0.30
$0.41
Q2 24
$0.36
$-0.09
Q1 24
$0.36
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NSSC
NSSC
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$115.4M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$184.8M
$130.3M
Total Assets
$212.8M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NSSC
NSSC
PBYI
PBYI
Q4 25
$115.4M
$97.5M
Q3 25
$105.8M
$94.4M
Q2 25
$99.2M
$96.0M
Q1 25
$89.3M
$93.2M
Q4 24
$99.2M
$101.0M
Q3 24
$91.3M
$96.7M
Q2 24
$70.7M
$96.8M
Q1 24
$60.9M
$107.2M
Total Debt
NSSC
NSSC
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
NSSC
NSSC
PBYI
PBYI
Q4 25
$184.8M
$130.3M
Q3 25
$176.1M
$115.3M
Q2 25
$168.6M
$104.7M
Q1 25
$161.5M
$97.1M
Q4 24
$174.2M
$92.1M
Q3 24
$178.6M
$71.1M
Q2 24
$178.9M
$48.5M
Q1 24
$168.2M
$51.0M
Total Assets
NSSC
NSSC
PBYI
PBYI
Q4 25
$212.8M
$216.3M
Q3 25
$206.0M
$202.9M
Q2 25
$198.1M
$194.9M
Q1 25
$190.9M
$196.2M
Q4 24
$202.7M
$213.3M
Q3 24
$209.9M
$220.7M
Q2 24
$207.8M
$205.0M
Q1 24
$194.8M
$214.1M
Debt / Equity
NSSC
NSSC
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NSSC
NSSC
PBYI
PBYI
Operating Cash FlowLast quarter
$15.1M
$14.4M
Free Cash FlowOCF − Capex
$14.5M
$14.4M
FCF MarginFCF / Revenue
30.1%
19.1%
Capex IntensityCapex / Revenue
1.2%
0.0%
Cash ConversionOCF / Net Profit
1.12×
TTM Free Cash FlowTrailing 4 quarters
$53.7M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NSSC
NSSC
PBYI
PBYI
Q4 25
$15.1M
$14.4M
Q3 25
$11.6M
$9.7M
Q2 25
$14.6M
$14.1M
Q1 25
$13.4M
$3.6M
Q4 24
$13.5M
$15.6M
Q3 24
$12.0M
$11.0M
Q2 24
$14.3M
$1.0M
Q1 24
$12.3M
$11.2M
Free Cash Flow
NSSC
NSSC
PBYI
PBYI
Q4 25
$14.5M
$14.4M
Q3 25
$11.4M
$9.7M
Q2 25
$14.4M
$14.1M
Q1 25
$13.3M
$3.6M
Q4 24
$12.4M
$15.6M
Q3 24
$11.3M
$11.0M
Q2 24
$13.8M
$1.0M
Q1 24
$12.0M
FCF Margin
NSSC
NSSC
PBYI
PBYI
Q4 25
30.1%
19.1%
Q3 25
23.3%
17.7%
Q2 25
28.4%
26.8%
Q1 25
30.3%
7.7%
Q4 24
28.8%
26.4%
Q3 24
25.8%
13.7%
Q2 24
27.4%
2.1%
Q1 24
24.3%
Capex Intensity
NSSC
NSSC
PBYI
PBYI
Q4 25
1.2%
0.0%
Q3 25
0.4%
0.0%
Q2 25
0.5%
0.0%
Q1 25
0.1%
0.1%
Q4 24
2.6%
0.0%
Q3 24
1.5%
0.0%
Q2 24
1.1%
0.0%
Q1 24
0.7%
0.0%
Cash Conversion
NSSC
NSSC
PBYI
PBYI
Q4 25
1.12×
Q3 25
0.96×
1.10×
Q2 25
1.26×
2.41×
Q1 25
1.32×
1.21×
Q4 24
1.29×
Q3 24
1.08×
0.54×
Q2 24
1.06×
Q1 24
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons